Turkish Version of Digital Eye Strain Questionnaire (DESQ)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT06054542 |
Recruitment Status :
Not yet recruiting
First Posted : September 26, 2023
Last Update Posted : September 26, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Cultural Adaptation Reliability Validity Adults Eye Strain | Other: Cultural adaptation, reliability and validity |
Study Type : | Observational |
Estimated Enrollment : | 130 participants |
Observational Model: | Other |
Time Perspective: | Prospective |
Official Title: | Validity and Reliability of the Turkish Version of Digital Eye Strain Questionnaire (DESQ) |
Estimated Study Start Date : | October 2023 |
Estimated Primary Completion Date : | May 2024 |
Estimated Study Completion Date : | June 2024 |
- Other: Cultural adaptation, reliability and validity
Cross-cultural Adaptation, Reliability and Validity of the Turkish Version of the DESQ
- DESQ [ Time Frame: 10 minutes ]Digital Eye Strain Questionnaire (DESQ) is a thirteen-item self-report scale in a yes-no format designed to offer a measure of complaints related to digital eye strain syndrome (DES)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Between the ages of 18-65 years
- People who spend two or more continuous hours a day on their digital devices (computer, tablet, smartphone) or use more than one device
Exclusion Criteria:
- History of ophthalmic surgery or active ocular disease
- Participants who did not understand the instructions or did not sign a consent form were excluded
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06054542
Contact: Ayşe Ünal, Assoc. Prof. | +90(242)510 6060 ext 4329 | pt.aunal@gmail.com | |
Contact: Ayça Aracı, Asst. Prof. | +90(242)510 6060 ext 4338 | ayca.araci@alanya.edu.tr |
Responsible Party: | Ayse Unal, Assoc. Prof., Alanya Alaaddin Keykubat University |
ClinicalTrials.gov Identifier: | NCT06054542 |
Other Study ID Numbers: |
20.09.2023/DESQ |
First Posted: | September 26, 2023 Key Record Dates |
Last Update Posted: | September 26, 2023 |
Last Verified: | September 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Asthenopia Sprains and Strains Wounds and Injuries Eye Diseases |